Feedback / Questions
FYB201 (ranibizumab biosimilar) - Amneal, Formycon
https://www.pharmiweb.com/press-release/2019-05-13/formycon-ag-formycon-announces-news-on-development-portfolio
May 13, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next